Research on biological age is becoming increasingly popular globally, yet Lithuania has not widely embraced this trend, which is crucial for preventive medicine.
The evaluation of biological age is considered one of the most advanced areas in preventive medicine worldwide. This approach assesses how fast a person's body is aging, based on biological processes at the cellular and tissue level, rather than simply relying on chronological age. According to Dr. V. DirsÄ—, two 50-year-olds can have entirely different biological ages, with one potentially being as biologically young as 40 and the other as old as 60. Measuring biological age helps to understand the true health status of an individual and can reveal accelerated aging processes before symptoms manifest, allowing for early preventive measures.
In many parts of the world, such biological age assessments are becoming standard in personalized medicine and longevity research, significantly altering how healthcare is approached. For instance, the shift from reactive medicine, which focuses on treating diseases after they develop, to preventive and personalized strategies represents a major transformation in medical practice. However, in Lithuania, despite the promising potential of biological age research, it has not yet gained significant traction among healthcare providers or the general population.
Moreover, there is a sobering statistic that indicates more than half of Lithuanians are overweight, demonstrating a preference for cost over health. This context suggests that there may be barriers to adopting progressive health practices such as biological age assessment. The article highlights the need for greater awareness and integration of such pioneering health measures in Lithuania as the country navigates existing public health challenges.
